Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

被引:171
作者
Mesters, RM
Helterbrand, J
Utterback, BG
Yan, SB
Chao, YB
Fernandez, JA
Griffin, JH
Hartman, DL
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Cardiovasc Res Div, Indianapolis, IN 46285 USA
[2] Univ Munster, Dept Med, D-4400 Munster, Germany
[3] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
[4] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
关键词
protein C; sepsis; septic shock; severe sepsis; leukemia; DIC; activated protein C; D-dimer;
D O I
10.1097/00003246-200007000-00005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the prognostic value of protein C, endogenous activated protein C, and D-dimer concentrations in patients at high risk of developing severe septic complications secondary to cytostatic chemotherapy, Design: Prospective, comparative, single-center study. Setting: Specialized ward for treating patients with acute leukemia and associated intensive care unit at a university hospital. Subjects: Twenty-six consecutive patients who developed either severe sepsis (n = 13) or septic shock (n = 13) during chemotherapy-induced neutropenia (leukocytes <1000/mu L), Intervention: None, other than standard care. Measurements and Main Results: Baseline blood samples were obtained from 97 adult patients treated with intensive cytostatic chemotherapy. Serial blood sampling was performed in 62 of 97 patients who developed fever (> 38.3 degrees C), Thirteen patients progressed to severe sepsis and 13 patients to septic shock. Protein C, endogenous activated protein C, and D-dimer were measured in these 26 patients. At fever onset, protein C concentrations decreased from normal baseline concentrations and were significantly lower in the group of patients who progressed to septic shock compared with those who developed severe sepsis (medians for protein C activity: 23.1% vs, 69.5%; p = .0003), The median elapsed time between detection of fever and the diagnosis of severe sepsis or septic shock was 16 hrs and 12 hrs, respectively, All septic shock patients died, whereas patients who progressed only to severe sepsis survived. Conclusions: Septic shock in neutropenic patients is associated with increased protein C consumption. The data demonstrate that the coagulation cascade is activated and produces a hypercoagulable state before the onset of clinical symptoms of severe sepsis and septic shock. Low protein C concentrations at the onset of fever and before the onset of clinical symptoms of severe sepsis or septic shock may have prognostic Value in predicting an unfavorable outcome. Protein C measurements may help identify patients at risk in an early phase of neutropenic sepsis, It is also attractive to speculate that because low protein C concentrations were seen in these patients, protein C replacement may be beneficial in sepsis.
引用
收藏
页码:2209 / 2216
页数:8
相关论文
共 73 条
  • [1] ACTIVATION OF THE PROTEIN-C PATHWAY IN ACUTE SEPSIS
    ALCARAZ, A
    ESPANA, F
    SANCHEZCUENCA, J
    ZUAZU, I
    ESTELLES, A
    AZNAR, J
    VICENTE, V
    [J]. THROMBOSIS RESEARCH, 1995, 79 (01) : 83 - 93
  • [2] STUDY OF THE BALANCE BETWEEN COAGULATION AND FIBRINOLYSIS IN DISSEMINATED INTRAVASCULAR COAGULATION USING MOLECULAR MARKERS
    ASAKURA, H
    JOKAJI, H
    SAITO, M
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    AOSHIMA, K
    MATSUDA, T
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) : 829 - 832
  • [3] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [5] SEPSIS SYNDROME - A VALID CLINICAL ENTITY
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (05) : 389 - 393
  • [6] Medicine and Mephistopheles
    Bone, RC
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (07) : 1099 - 1100
  • [7] THE QUANTITATIVE ASSOCIATION OF PLASMA ENDOTOXIN, ANTITHROMBIN, PROTEIN-C, EXTRINSIC PATHWAY INHIBITOR AND FIBRINOPEPTIDE-A IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    SANDSET, PM
    JOO, GB
    OVSTEBO, R
    ABILDGAARD, U
    KIERULF, P
    [J]. THROMBOSIS RESEARCH, 1989, 55 (04) : 459 - 470
  • [8] CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196
  • [9] Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P31
  • [10] TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS
    CONWAY, EM
    ROSENBERG, RD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) : 5588 - 5592